CD44 and breast cancer: All sphere and monolayer derivative cell models investigated in this report exhibit a unique CD24−/CD44+ marker distribution, although only the S2N spheres were highly tumorigenic at low inoculation cell numbers in vivo (Figs. 1 and 4; confirmed in 2 more primary breast cancer cell models, data not shown).